Cutaneous melanoma: From pathogenesis to therapy (Review).
Cutaneous melanoma: From pathogenesis to therapy (Review).
复制标题
DOI:
10.3892/ijo.2018.4287
复制
发表时间:
2018-04
影响因子:
5.2
通讯作者:
Libra M
中科院分区:
文献类型:
--
作者:
Leonardi GC;Falzone L;Salemi R;Zanghì A;Spandidos DA;Mccubrey JA;Candido S;Libra M
In less than 10 years, melanoma treatment has been revolutionized with the approval of tyrosine kinase inhibitors and immune checkpoint inhibitors, which have been shown to have a significant impact on the prognosis of patients with melanoma. The early steps of this transformation have taken place in research laboratories. The mitogen-activated protein kinase (MAPK) pathway, phosphoinositol-3-kinase (PI3K) pathway promote the development of melanoma through numerous genomic alterations on different components of these pathways. Moreover, melanoma cells deeply interact with the tumor microenvironment and the immune system. This knowledge has led to the identification of novel therapeutic targets and treatment strategies. In this review, the epidemiological features of cutaneous melanoma along with the biological mechanisms involved in its development and progression are summarized. The current state-of-the-art of advanced stage melanoma treatment strategies and the currently available evidence of the use of predictive and prognostic biomarkers are also discussed.
登录
查看更多内容
影响因子:
11.2
作者:
Donia, Marco;Harbst, Katja;Svane, Inge Marie
通讯作者:
Svane, Inge Marie
影响因子:
5.6
作者:
Banna GL;Torino F;Marletta F;Santagati M;Salemi R;Cannarozzo E;Falzone L;Ferraù F;Libra M
通讯作者:
Libra M
DOI:
10.1034/j.1600-0749.2003.00047.x
发表时间:
2003-06-01
期刊:
PIGMENT CELL RESEARCH
影响因子:
--
作者:
Bauer, J;Garbe, C
通讯作者:
Garbe, C
影响因子:
--
作者:
Bevona, C;Goggins, W;Tsao, H
通讯作者:
Tsao, H
影响因子:
4.2
作者:
Candido S;Rapisarda V;Marconi A;Malaponte G;Bevelacqua V;Gangemi P;Scalisi A;McCubrey JA;Maestro R;Spandidos DA;Fenga C;Libra M
通讯作者:
Libra M